磺酰脲受体
内科学
内分泌学
医学
钾通道
糖尿病
磺酰脲
2型糖尿病
错义突变
突变
格列本脲
生物
生物化学
基因
作者
Andrey P. Babenko,Michel Polak,Hélène Cavé,Kanetee Busiah,Paul Czernichow,Raphaël Scharfmann,Joseph Bryan,Lydia Aguilar‐Bryan,Martine Vaxillaire,Philippe Froguel
摘要
The ATP-sensitive potassium (KATP) channel, composed of the beta-cell proteins sulfonylurea receptor (SUR1) and inward-rectifying potassium channel subunit Kir6.2, is a key regulator of insulin release. It is inhibited by the binding of adenine nucleotides to subunit Kir6.2, which closes the channel, and activated by nucleotide binding or hydrolysis on SUR1, which opens the channel. The balance of these opposing actions determines the low open-channel probability, PO, which controls the excitability of pancreatic beta cells. We hypothesized that activating mutations in ABCC8, which encodes SUR1, cause neonatal diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI